MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 274 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 1.27 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 130,529 | $34,856,464 | 33.02% |
| Paulson & Co. | 1,775,000 | $473,996,000 | 32.74% |
| University of Wisconsin Foundation | 56,376 | $15,054,647 | 16.99% |
| AlpInvest Partners B.V. | 105,744 | $28,237,878 | 11.03% |
| Propel Bio Management, LLC | 43,032 | $11,491,265 | 6.69% |
| Baker Brothers Advisors | 1,969,798 | $526,014,858 | 6.60% |
| Avoro Capital Advisors LLC | 1,944,444 | $519,244,326 | 6.06% |
| Tri Locum Partners LP | 53,355 | $14,247,919 | 4.94% |
| Bain Capital Life Sciences Investors, LLC | 196,995 | $52,605,545 | 4.23% |
| Sio Capital Management, LLC | 51,000 | $13,619,040 | 4.06% |
| Affinity Asset Advisors, LLC | 115,000 | $30,709,600 | 3.80% |
| 683 Capital Management, LLC | 177,900 | $47,506,416 | 3.48% |
| TCG Crossover Management, LLC | 149,283 | $39,864,532 | 3.15% |
| MPM BioImpact LLC | 61,399 | $16,395,989 | 2.64% |
| Perceptive Advisors | 429,953 | $114,814,649 | 2.01% |
| Rock Springs Capital Management LP | 285,931 | $76,355,014 | 1.94% |
| Exome Asset Management LLC | 7,900 | $2,109,616 | 1.81% |
| RTW INVESTMENTS, LP | 397,047 | $106,027,431 | 1.56% |
| Ikarian Capital, LLC | 51,400 | $13,725,856 | 1.50% |
| Rheos Capital Works Inc. | 110,215 | $29,432 | 1.41% |
External links
This page lists MADRIGAL PHARMACEUTICALS INC's shareholders in Q1 2024. To view MADRIGAL PHARMACEUTICALS INC's shareholder history, click here.